| Filed On | Filing |
|---|---|
| 14 Feb 2022 | SCHEDULE 13G (AMENDMENT NO. 1) |
| 19 Nov 2021 | 15-12B |
| 15 Nov 2021 | EFFECT |
| 15 Nov 2021 | EFFECT |
| 09 Nov 2021 |
Form 4: Miller-Rich Nancy, Director
Disposed of 133,339 Stock Option (right to buy) (Disposition to Issuer) ($768K) |
| 09 Nov 2021 |
Form 4: Carver Kyle, SVP, CAO, Controller
Returned 15,420 shares to the issuer ($146K) · Disposed of 425,000 Stock Option (right to buy) (Disposition to Issuer) ($2.38M) |
| 09 Nov 2021 |
Form 4: Bauer Eugene, Director
Returned 6,716 shares to the issuer ($63.8K) · Disposed of 335,086 Stock Option (right to buy) (Disposition to Issuer) ($2.03M) |
| 09 Nov 2021 |
Form 4: Waksal Harlan, Director
Returned 177,945 shares to the issuer ($1.69M) · Acquired 655,000 Stock Appreciation Right (Disposition to Issuer) ($3.84M) · Acquired 982,500 Performance Stock Option(right to buy) (Disposition to Issuer) ($5.34M) · 2 more |
| 09 Nov 2021 |
Form 4: Flowers Cynthia Louise, Director
Gave 20,150 shares as a gift · Returned 10,850 shares to the issuer ($103K) · Disposed of 346,944 Stock Option (right to buy) (Disposition to Issuer) ($2.19M) |
| 09 Nov 2021 |
Form 4: Ryan John L, EVP, Chief Medical Officer
Disposed of 575,000 Stock Option (right to buy) (Disposition to Issuer) ($3.2M) · Disposed of 250 Equity Appreciation Rights Unit (Disposition to Issuer) ($875) |
| 09 Nov 2021 |
Form 4: Kirsch Arthur S, Director
Returned 30,000 shares to the issuer ($285K) · Disposed of 346,112 Stock Option (right to buy) (Disposition to Issuer) ($2.19M) |
| 09 Nov 2021 |
Form 4: Moss Gregory S., EVP, Gen. Coun. / CCO.
Returned 17,671 shares to the issuer ($168K) · Disposed of 75,000 Stock Appreciation Right (Disposition to Issuer) ($363K) · Disposed of 150,000 Performance Stock Option (right to buy) (Disposition to Issuer) ($879K) · 2 more |
| 09 Nov 2021 |
Form 4: Meehan Steven, EVP, Chief Financial Officer
Returned 24,909 shares to the issuer ($237K) · Disposed of 1,970,000 Stock Option (right to buy) (Disposition to Issuer) ($11.5M) |
| 09 Nov 2021 |
Form 4: Cohen David E, Director
Disposed of 346,944 Stock Option (right to buy) (Disposition to Issuer) ($2.19M) |
| 09 Nov 2021 |
Form 4: Konidaris Tasos, Director
Disposed of 418,410 Stock Option (right to buy) (Disposition to Issuer) ($2.5M) |
| 09 Nov 2021 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
SECTION 1. Annual Meetings. The annual meeting of the stockholders of Kadmon Holdings, Inc. (the “Corporation”) for the election of directors and for the transaction of such other business as may properly come before the meeting shall be... |
| 09 Nov 2021 | S-8 POS |
| 09 Nov 2021 | S-8 POS |
| 09 Nov 2021 | S-8 POS |
| 09 Nov 2021 | S-8 POS |
Loading...